References
- Nigro G, Adler SP, La Torre R, et al. Passive immunization during pregnancy for congenital Cytomegalovirus infection. N Engl J Med 2005;353:1350–62
- La Torre R, Nigro G, Mazzocco M, et al. Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease. Clin Infect Dis 2006;43:994–1000
- Maidji E, Nigro G, Tabata T, et al. Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection. Am J of Pathol 2010;177:1298–310
- Bissinger AL, Sinzger C, Kaiserling E, Jahn G. Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease. J Med Virol 2002; 67:200–6
- Goegebuer T, Van Meensel B, Beuselinck K, et al. Clinical predictive value of real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples. J Clin Microbiol 2009;47:660–5
- Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007;17:253–76
- Berger A, Reitter A, Harter PN, et al. Problems and challenges in the diagnosis of vertical infection with human cytomegalovirus (CMV): lessons from two accidental cases. J Clin Virol 2011;51:285–8
- Abdel-Fattah SA, Bhat A, Illanes S, et al. TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom. Prenat Diagn 2005;25:1028–31
- Cheeran MCJ, Lohensgard JR, Schleiss MR. Neuropathogenesis of congenital cytomegalovirus infection: disease, mechanisms and prospects for intervention. Clin Microbiol Rev 2009;22:99–126
- Benoist G, Salomon LJ, Jacquemard F, et al. The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus. BJOG 2008;115:823–9
- Guerra B, Simonazzi G, Puccetti C, et al. Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 2008;198:380.e1–7
- Moxley K, Knudtson EJ. Resolution of hydrops secondary to cytomegalovirus after maternal and fetal treatment with human cytomegalovirus hyperimmune globulin. Obstet Gynecol 2008;111:524–6
- Moise KJ, Wolfe H. Treatment of second trimester fetal cytomegalovirus infection with maternal hyperimmune globulin. Prenat Diagn 2008;28:264–5
- Nigro G, La Torre R, Pentimalli H, et al. Regression of fetal cerebral abnormalities by primary catomegalovirus infection following hyperimmunoglobulin therapy. Prenatal Diagn 2008;28:512–17
- Pass RF, Zhang C, Evans A, et al. Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 2009;360:1191–9
- Jacquemard F, Yamamoto M, Costa JM, et al. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG 2007;114:1113–21
- Cannon MJ, Davis KF. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Publ Health 2005;20:70--77
- Vauloup-Fellous C, Picone O, Cordier AG, et al. Does hygiene counselling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital. J Clin Virol 2009;46S:S49–53
- Grangeot-Keros L, Mayaux MJ, Lebon P, et al. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J Infect Dis 1997;175:944–6
- Rothe M, Pepperl-Klindworth S, Lang D, et al. An antigen fragment encompassing the AD2 domains of glycoprotein B from two different strains is sufficient for differentiation of primary vs. recurrent human cytomegalovirus infection by ELISA. J Med Virol 2001;65:719–29
- Eggers M, Bäder U, Enders G. Combination of microneutralization and avidity assays: improved diagnosis of recent primary human cytomegalovirus infection in single serum sample of second trimester pregnancy. J Med Virol 2000;60:324–30
- Revello MG, Furione M, Zavattoni M, et al. Human cytomegalovirus (HCMV) DNAemia in the mother at amniocentesis as a risk factor for iatrogenic HCMV infection of the fetus. J Infect Dis 2008;197:593–6
- Lazzarotto T, Guerra B, Lanari M, et al. New advances in the diagnosis of congenital cytomegalovirus infection. J Clin Virol 2008;41:192–7
- Adler SP, Nigro G. The importance of cytomegalovirus-specific antibodies for the prevention of fetal cytomegalovirus infection or disease. Herpes 2008;15:24–7
- Adler SP, Nigro G. Findings and conclusions from CMV hyperimmune globulin treatment trials. J Clin Virol 2009;46:S54–7